DB Alex Brown Boosts Guidant to 'Strong Buy'

Analyst Sheryl Zimmer says the drug maker's stent development deal puts it just behind Johnson & Johnson

DB Alex Brown upgraded Guidant Corp. (GDT ) to strong buy from buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.